EVLV on Nasdaq
Evolv Technologies Holdings, Inc.
Computer peripheral equipment company, listed on Nasdaq (EVLV)1
In its 2026 annual report the company says: “Evolv Technologies Holdings, Inc., a Delaware corporation formed in 2021 is a leading security technology company pioneering Artificial Intelligence-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. We serve customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces.”4 It is headquartered in Waltham, Massachusetts.1
Price unavailable
Last updated Oct 20, 2026.
Overview
Compare with Planet Image International Ltd, RYB Education or MITEK SYSTEMS INC, or pick any stock.
- TickerEVLV on Nasdaq1
- IndustryComputer Peripheral Equipment, NEC1
- HeadquartersWaltham, Massachusetts1
- Business address500 Totten Pond Road, 4Th Floor, Waltham, Ma 024512
- Filer categoryNon-accelerated filer2
See how the biggest companies compare on our leaderboards
Evolv Technologies Holdings, Inc., a Delaware corporation formed in 2021 (“we,” “us,” “our,” the “Company” and “Evolv”) is a leading security technology company pioneering Artificial Intelligence (“AI”)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. We serve customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. Our mission is to make the world a safer and more enjoyable place to live, work, learn, and play. Our goal is to help facility operators address escalating gun violence, mass shootings and terrorist attacks while maintaining a positive visitor experience.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
51.6%Gross margin5
-33.2%Operating margin5
-22.7%Net margin5
40.5%Revenue growth, 20255
-27.7%Return on equity5
0.24×Debt to equity5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Subscription and Circulation brought in 57% of the revenue Evolv Technologies Holdings, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Subscription and Circulation | $65.0M | $83.8M |
| SaaS, Maintenance and Other | $23.5M | $29.4M |
| Product | $6.5M | $21.6M |
| License Fee | $7.2M | $8.1M |
| Professional Services and Other Revenue | $1.7M | $3.0M |
Regions
United States brought in 96% of the revenue Evolv Technologies Holdings, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $100.0M | $140.7M |
| Outside the United States | $3.9M | $5.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue48¢$70.6M
- Research and development14¢$20.6M
- Other costs37¢$54.6M
- Income tax0¢$62.0K
Out of $145.9M in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$18.7M
Out of $18.7M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenue | $145.9M | $103.9M |
| Total cost of revenue | $70.6M | $44.4M |
| Gross profit | $75.3M | $59.5M |
| Research and development | $20.6M | $23.4M |
| Sales and marketing | $45.6M | $60.6M |
| General and administrative | $54.9M | $56.6M |
| Restructuring costs | $2.7M | $860.0K |
| Loss on impairment of property and equipment | $0 | $224.0K |
| Total operating expenses | $123.8M | $141.8M |
| Loss from operations | -$48.5M | -$82.3M |
| Interest expense | -$1.7M | $0 |
| Interest income | $1.5M | $2.9M |
| Other income (expense), net | $99.0K | -$83.0K |
| Change in fair value of contingent earn-out liability | $12.4M | $16.3M |
| Change in fair value of contingently issuable/returnable common stock liability/asset | $2.6M | $2.5M |
| Change in fair value of public warrant liability | $435.0K | $6.6M |
| Total other income, net | $15.4M | $28.3M |
| Loss before income taxes | -$33.1M | -$54.0M |
| Provision for income taxes | $62.0K | $0 |
| Net loss | -$33.1M | -$54.0M |
| Weighted average common shares outstanding - basic (in shares) | 168.4M shares | 156.6M shares |
| Weighted average common shares outstanding - diluted (in shares) | 168.4M shares | 156.6M shares |
| Net loss per share - basic (in dollars per share) | -$0.20 | -$0.34 |
| Net loss per share - diluted (in dollars per share) | -$0.20 | -$0.34 |
| Cumulative translation adjustment | -$109.0K | $21.0K |
| Total other comprehensive (loss) income | -$109.0K | $21.0K |
| Total comprehensive loss | -$33.2M | -$54.0M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $49.1M | $37.0M | |
| Marketable securities | $19.9M | $14.9M | |
| Accounts receivable, net of allowance for expected credit losses of $600 and $734 as of December 31, 2025 and December 31, 2024, respectively | $30.8M | $28.4M | |
| Inventory | $9.3M | $17.0M | |
| Current portion of contract assets | $878.0K | $799.0K | |
| Current portion of commission asset | $6.1M | $5.4M | |
| Prepaid expenses and other current assets | $35.2M | $17.9M | |
| Total current assets | $151.3M | $121.4M | |
| Contract assets, noncurrent | $15.0K | $657.0K | |
| Commission asset, noncurrent | $7.9M | $7.6M | |
| Property and equipment, net | $127.5M | $123.7M | |
| Operating lease right-of-use assets | $12.3M | $14.0M | |
| Other assets | $5.4M | $735.0K | |
| Total assets | $304.4M | $268.1M | |
| Accounts payable | $9.8M | $10.5M | |
| Accrued expenses and other current liabilities | $35.3M | $19.5M | |
| Current portion of deferred revenue | $74.9M | $64.5M | |
| Current portion of operating lease liabilities | $3.0M | $2.2M | |
| Total current liabilities | $123.0M | $96.7M | |
| Deferred revenue, noncurrent | $16.7M | $20.3M | |
| Long-term debt | $28.6M | $0 | |
| Operating lease liabilities, noncurrent | $10.7M | $12.3M | |
| Contingent earn-out liability, noncurrent | $374.0K | $12.8M | |
| Contingently issuable common stock liability, noncurrent | $1.8M | $4.0M | |
| Public warrant liability, noncurrent | $3.9M | $4.3M | |
| Total liabilities | $185.0M | $150.4M | |
| Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2025 and December 31, 2024; no shares issued and outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2025 and December 31, 2024, 175,399,488 and 159,602,069 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $18.0K | $16.0K | |
| Additional paid-in capital | $507.3M | $472.3M | |
| Accumulated other comprehensive loss | -$141.0K | -$32.0K | |
| Accumulated deficit | -$387.8M | -$354.7M | |
| Stockholders equity | $119.4M | $117.7M | $144.1M |
| Total liabilities and stockholders equity | $304.4M | $268.1M | |
| Allowance for expected credit losses | $600.0K | $734.0K | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 1.1B shares | 1.1B shares | |
| Common stock, issued (in shares) | 175.4M shares | 159.6M shares | |
| Common stock, outstanding (in shares) | 175.4M shares | 159.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $49.1M | $37.0M | |
| Marketable securities | $19.9M | $14.9M | |
| Accounts receivable, net of allowance for expected credit losses of $600 and $734 as of December 31, 2025 and December 31, 2024, respectively | $30.8M | $28.4M | |
| Inventory | $9.3M | $17.0M | |
| Current portion of contract assets | $878.0K | $799.0K | |
| Current portion of commission asset | $6.1M | $5.4M | |
| Prepaid expenses and other current assets | $35.2M | $17.9M | |
| Total current assets | $151.3M | $121.4M | |
| Contract assets, noncurrent | $15.0K | $657.0K | |
| Commission asset, noncurrent | $7.9M | $7.6M | |
| Property and equipment, net | $127.5M | $123.7M | |
| Operating lease right-of-use assets | $12.3M | $14.0M | |
| Other assets | $5.4M | $735.0K | |
| Total assets | $304.4M | $268.1M | |
| Accounts payable | $9.8M | $10.5M | |
| Accrued expenses and other current liabilities | $35.3M | $19.5M | |
| Current portion of deferred revenue | $74.9M | $64.5M | |
| Current portion of operating lease liabilities | $3.0M | $2.2M | |
| Total current liabilities | $123.0M | $96.7M | |
| Deferred revenue, noncurrent | $16.7M | $20.3M | |
| Long-term debt | $28.6M | $0 | |
| Operating lease liabilities, noncurrent | $10.7M | $12.3M | |
| Contingent earn-out liability, noncurrent | $374.0K | $12.8M | |
| Contingently issuable common stock liability, noncurrent | $1.8M | $4.0M | |
| Public warrant liability, noncurrent | $3.9M | $4.3M | |
| Total liabilities | $185.0M | $150.4M | |
| Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2025 and December 31, 2024; no shares issued and outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2025 and December 31, 2024, 175,399,488 and 159,602,069 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $18.0K | $16.0K | |
| Additional paid-in capital | $507.3M | $472.3M | |
| Accumulated other comprehensive loss | -$141.0K | -$32.0K | |
| Accumulated deficit | -$387.8M | -$354.7M | |
| Stockholders equity | $119.4M | $117.7M | $144.1M |
| Total liabilities and stockholders equity | $304.4M | $268.1M | |
| Allowance for expected credit losses | $600.0K | $734.0K | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 100.0M shares | 100.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 1.1B shares | 1.1B shares | |
| Common stock, issued (in shares) | 175.4M shares | 159.6M shares | |
| Common stock, outstanding (in shares) | 175.4M shares | 159.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$33.1M | -$54.0M |
| Depreciation and amortization | $24.3M | $17.4M |
| Write-off of inventory and change in inventory reserve | $2.9M | $2.6M |
| Loss on impairment of property and equipment | $0 | $224.0K |
| Loss on impairment of intangible asset | $0 | $983.0K |
| Loss on disposal of property and equipment | $3.8M | $0 |
| Stock-based compensation | $21.1M | $24.8M |
| Non-cash interest expense | $482.0K | $0 |
| (Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest | -$126.0K | $447.0K |
| Non-cash lease expense | $1.7M | $1.4M |
| Change in allowance for expected credit losses | -$134.0K | $152.0K |
| Change in fair value of earn-out liability | -$12.4M | -$16.3M |
| Change in fair value of contingently issuable/returnable common stock liability/asset | -$2.6M | -$2.5M |
| Change in fair value of public warrant liability | -$435.0K | -$6.6M |
| Accounts receivable | -$2.3M | -$7.0M |
| Inventory | $9.1M | -$7.9M |
| Commission assets | -$933.0K | -$1.4M |
| Contract assets | $563.0K | $905.0K |
| Other assets | $750.0K | $467.0K |
| Prepaid expenses and other current assets | -$22.6M | -$964.0K |
| Accounts payable | $3.8M | $192.0K |
| Deferred revenue | $6.9M | $12.8M |
| Accrued expenses and other current liabilities | $18.9M | $4.5M |
| Operating lease liability | -$886.0K | -$1.1M |
| Net cash provided by (used in) operating activities | $18.7M | -$30.9M |
| Development of internal-use software | -$5.6M | -$6.1M |
| Purchases of property and equipment | -$31.4M | -$31.2M |
| Purchases of marketable securities | -$39.4M | -$29.4M |
| Proceeds from maturities of marketable securities | $34.6M | $65.3M |
| Net cash used in investing activities | -$41.8M | -$1.4M |
| Proceeds from exercise of stock options | $9.1M | $1.8M |
| Proceeds from long-term debt | $26.3M | $0 |
| Net cash provided by financing activities | $35.4M | $1.8M |
| Effect of exchange rate changes on cash and cash equivalents | -$109.0K | $21.0K |
| Net increase (decrease) in cash and cash equivalents | $12.1M | -$30.4M |
| Cash paid for interest | $1.2M | $0 |
| Transfer of property and equipment to inventory | $4.5M | $1.3M |
| Capital expenditures incurred but not yet paid | $3.7M | $5.5M |
| Capitalization of stock compensation | $1.1M | $941.0K |
| Operating lease liabilities arising from obtaining right-of-use assets | $0 | $14.2M |
| Conversion of contingently issuable common stock | $3.7M | $0 |
No quarter-by-quarter statement was filed.
Compare Evolv Technologies Holdings, Inc. with another company
Corporate structure
Evolv Technologies Holdings, Inc. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Evolv Technologies Holdings, Inc.
- BlackRock Filed SCHEDULE 13G/A on Evolv Technologies Holdings, Inc., latest Jul 28, 2026 (3 filings since Oct 24, 2024)
- General Catalyst Group Management Holdings GP, LLC Filed SCHEDULE 13G/A on Evolv Technologies Holdings, Inc., latest Apr 17, 2026 (3 filings since Feb 15, 2022)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Evolv Technologies Holdings, Inc., latest Mar 26, 2026 (4 filings since Nov 4, 2024)
- Gates Frontier, LLC Filed SCHEDULE 13G/A on Evolv Technologies Holdings, Inc., latest Sep 22, 2025 (2 filings since Feb 13, 2023)
- Data Collective IV, L.P. Filed SCHEDULE 13D/A on Evolv Technologies Holdings, Inc., latest Aug 22, 2025 (2 filings since Nov 17, 2023)
- Stoic Point Capital Management LLC Filed SCHEDULE 13D/A on Evolv Technologies Holdings, Inc., latest Aug 19, 2025 (5 filings since Nov 7, 2024)
- Lux Venture Partners III, LLC Filed SC 13D/A on Evolv Technologies Holdings, Inc., latest Feb 14, 2024 (2 filings since Sep 6, 2022)
- Michael Ellenbogen Filed SC 13D on Evolv Technologies Holdings, Inc., latest Jan 30, 2023
- GLENVIEW CAPITAL MANAGEMENT, LLC Filed SC 13G/A on Evolv Technologies Holdings, Inc., latest Feb 14, 2022
- OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) Filed SC 13G/A on Evolv Technologies Holdings, Inc., latest Feb 14, 2022
- PERISCOPE CAPITAL INC. Filed SC 13G/A on Evolv Technologies Holdings, Inc., latest Feb 14, 2022
- Magnetar Financial LLC Filed SC 13G/A on Evolv Technologies Holdings, Inc., latest Jan 7, 2022
- Evolv Technologies Holdings, Inc. Waltham, Massachusetts
- Evolv Technology UK Ltd. Subsidiary · United Kingdom
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Evolv Technologies Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $185.5M5 Dec 31, 2025 | $157.1M5 Dec 31, 2024 | +18.1% |
| Accumulated depreciation | $58.0M5 Dec 31, 2025 | $33.4M5 Dec 31, 2024 | +73.7% |
| Property and equipment, net | $127.5M5 Dec 31, 2025 | $123.7M5 Dec 31, 2024 | +3.1% |
| Operating-lease assets (leased space) | $12.3M5 Dec 31, 2025 | $14.0M5 Dec 31, 2024 | −12.1% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $49.1M5 Dec 31, 2025 | $37.0M5 Dec 31, 2024 | +32.8% |
| Marketable securities, current | $19.9M5 Dec 31, 2025 | $14.9M5 Dec 31, 2024 | +33.2% |
| Debt securities available for sale | $19.9M5 Dec 31, 2025 | $14.9M5 Dec 31, 2024 | +33.2% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $9.3M5 Dec 31, 2025 | $17.0M5 Dec 31, 2024 | −45.1% |
| Raw materials | $3.3M5 Dec 31, 2025 | $4.4M5 Dec 31, 2024 | −25.0% |
| Finished goods | $5.3M5 Dec 31, 2025 | $12.2M5 Dec 31, 2024 | −56.2% |
Properties, in its own words
Our corporate headquarters is located in an approximately 96,000 square foot facility that we sublease in Waltham, Massachusetts. During the three months ended March 31, 2024, we amended the lease agreement to extend the term through October 31, 2025, with the option to further extend through June 30, 2031 with written notice. Additionally, in August 2024, we amended the lease agreement again to expand our footprint in our headquarters and extend the term of the lease through May 2031. Our executive offices are located at 500 Totten Pond Road, 4th Floor, Waltham, MA 02451 under the foregoing sublease. We believe that our office space is adequate for our current needs and, should we need additional space, we believe we will be able to obtain additional space on commercially reasonable terms.
Item 2 of the 10-K filed Mar 10, 2026.4
Leadership
Who has led Evolv Technologies Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2025
- Chief executive officerJohn Kedzierski Dec 16, 2024 to now14
- Chief executive officerKevin M. Charlton Jul 30, 2020 to Aug 6, 202015
- PresidentJohn Kedzierski Dec 16, 2024 to now14
- Chief financial officerGeorge C. Kutsor May 5, 2025 to now16
- Chief financial officerMark Donohue Jun 2, 2022 to Jun 4, 202417
- Chief financial officerPeter R. Faubert Jul 20, 2021 to Sep 28, 202118
- Chief financial officerMario Ramos Nov 3, 2021 to Mar 1, 202219
- Chief financial officerAdam Deutsch Jul 30, 2020 to Aug 6, 202020
- Chief operating officerCharlie Baynes-Reid Jul 30, 2020 to Aug 6, 202021
Board members and other officers (23)
- Chief Revenue OfficerRobert E. Marshall Feb 13, 2025 to now22
- Chief Commercial OfficerJay Muelhoefer Oct 20, 2023 to Nov 5, 202423
- Founder & Head of Corp. Dev.Anil Chitkara Jul 20, 2021 to now24
- Chief Revenue OfficerAnthony John Derosa Jul 20, 2021 to Dec 20, 202325
- Founder & Head of Adv. Tech.Michael Ellenbogen Jul 20, 2021 to now26
- Board memberHenrik Kuhl Feb 18, 2026 to now27
- Board memberRichard A. Shapiro Feb 13, 2025 to now28
- Board memberDavid Mounts Gonzales Nov 6, 2023 to now29
- Board memberRajan Naik Nov 6, 2023 to Nov 6, 202330
- Board memberJohn Kedzierski Jan 31, 2022 to now31
- Board memberBilal Zuberi Jul 20, 2021 to now32
- Board memberDavid J. Orfao Jul 20, 2021 to Jul 20, 202133
- Board memberKevin M. Charlton Jul 20, 2021 to now34
- Board memberKimberly H. Sheehy Jul 20, 2021 to now35
- Board memberMahesh Saptharishi Jul 20, 2021 to Jul 20, 202136
- Board memberMerline Saintil Jul 20, 2021 to Jun 14, 202437
- Board memberMichael Ellenbogen Jul 20, 2021 to now26
- Board memberBrian Mathis Jul 30, 2020 to Jul 30, 202038
- Board memberCharles Mathew Goldman Jul 30, 2020 to Aug 6, 202039
- Board memberKathleen M. Harris Jul 30, 2020 to Jul 30, 202040
- Board memberMarc Saiontz Jul 30, 2020 to Jul 30, 202041
- Board memberNeil Glat Jul 30, 2020 to now42
- Board memberSezaneh Taherian Jul 30, 2020 to Jul 30, 202043
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Evolv Technology UK Ltd. United Kingdom3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- NewHold Investment Corp.Mar 10, 2020 to Jun 29, 20212
Timeline
- Aug 11, 20268-K Results of operations44
- Aug 10, 20268-K Other events45
- Jun 22, 20268-K Shareholder vote46
- May 13, 20268-K Financial statements and exhibits47
- May 12, 20268-K Results of operations48
- Mar 10, 20268-K Results of operations49
- Feb 12, 20268-K Executive or director change; Regulation FD disclosure50
- Nov 13, 20258-K Results of operations51
- Aug 14, 20258-K Results of operations; Executive or director change52
- Jul 30, 20258-K Entered a material agreement53
- Jul 1, 20258-K Regulation FD disclosure54
- Jun 23, 20258-K Shareholder vote55
- Dec 16, 2024New chief executive John Kedzierski becomes CEO14
- Jul 30, 2020New chief executive Kevin M. Charlton becomes CEO15
Filings
404 filings to the SEC since October 2021: 5 annual reports, 17 quarterly reports, 59 major events, 213 insider forms, 28 large holders, 82 other. The latest 20:
- Oct 6, 20264 EDGAR
- Oct 6, 20264 EDGAR
- Sep 11, 2026144 EDGAR
- Sep 9, 20264 EDGAR
- Aug 19, 20264 EDGAR
- Aug 19, 2026144 EDGAR
- Aug 18, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 11, 202610-Q EDGAR
- Aug 11, 20268-K EDGAR
- Aug 11, 2026S-8 EDGAR
- Aug 10, 20268-K EDGAR
- Jul 28, 2026SCHEDULE 13G/A EDGAR
- Jul 17, 20264 EDGAR
- Jul 16, 202625-NSE EDGAR
- Jun 22, 20264 EDGAR
- Jun 22, 20264 EDGAR
- Jun 22, 20264 EDGAR
- Jun 22, 20264 EDGAR
- Jun 22, 20268-K EDGAR
The 404 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
113 open-market trades by officers, directors and large owners since October 2021: 16 buys and 97 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Shapiro Richard ADirector | Buy | 32,600 | $4.96 | $161.7K | Form 4 |
| Aug 17, 2026 | Ellenbogen MichaelDirector | Sale | 80,752 | $5.59 | $451.4K | Form 4 |
| Aug 14, 2026 | Kuhl HenrikDirector | Buy | 15,000 | $5.73 | $86.0K | Form 4 |
| Aug 14, 2026 | Glat NeilDirector | Buy | 8,500 | $5.74 | $48.8K | Form 4 |
| Jul 15, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $5.94 | $479.6K | Form 4 |
| Jun 15, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $6.21 | $501.4K | Form 4 |
| Jun 2, 2026 | Marshall Robert EChief Revenue Officer | Sale | 62,067 | $6.85 | $425.2K | Form 4 |
| May 15, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $5.63 | $454.6K | Form 4 |
| May 4, 2026 | Kutsor George CChief Financial Officer | Sale | 51,448 | $7.27 | $374.0K | Form 4 |
| Apr 15, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $6.32 | $510.3K | Form 4 |
| Mar 6, 2026 | Ellenbogen MichaelDirector | Sale | 91,771 | $5.10 | $468.0K | Form 4 |
| Mar 2, 2026 | Chitkara AnilFounder & Chief Growth Officer | Sale | 63,670 | $5.19 | $330.4K | Form 4 |
| Mar 2, 2026 | Ellenbogen MichaelDirector | Sale | 82,913 | $5.19 | $430.3K | Form 4 |
| Feb 17, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $5.47 | $441.7K | Form 4 |
| Jan 16, 2026 | Ellenbogen MichaelDirector | Sale | 80,745 | $6.20 | $500.6K | Form 4 |
| Jan 5, 2026 | Kedzierski JohnPresident & CEO | Sale | 74,322 | $7.03 | $522.5K | Form 4 |
| Dec 15, 2025 | Ellenbogen MichaelDirector | Sale | 80,745 | $6.91 | $557.9K | Form 4 |
| Nov 25, 2025 | Marshall Robert EChief Revenue Officer | Buy | 7,000 | $6.06 | $42.4K | Form 4 |
| Nov 21, 2025 | Kedzierski JohnPresident & CEO | Buy | 8,000 | $5.91 | $47.3K | Form 4 |
| Nov 21, 2025 | Charlton Kevin M.Director | Buy | 15,000 | $5.68 | $85.2K | Form 4 |
All 113 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 3 filings Oct 24, 2024 to Jul 28, 202656
- General Catalyst Group Management Holdings GP, LLCSCHEDULE 13G/A, 3 filings Feb 15, 2022 to Apr 17, 202657
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Nov 4, 2024 to Mar 26, 202658
- Gates Frontier, LLCSCHEDULE 13G/A, 2 filings Feb 13, 2023 to Sep 22, 202559
- Data Collective IV, L.P.SCHEDULE 13D/A, 2 filings Nov 17, 2023 to Aug 22, 202560
- Stoic Point Capital Management LLCSCHEDULE 13D/A, 5 filings Nov 7, 2024 to Aug 19, 202561
- Lux Venture Partners III, LLCSC 13D/A, 2 filings Sep 6, 2022 to Feb 14, 202462
- Michael EllenbogenSC 13D, 1 filing Jan 30, 202363
- GLENVIEW CAPITAL MANAGEMENT, LLCSC 13G/A, 1 filing Feb 14, 202264
- OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)SC 13G/A, 1 filing Feb 14, 202265
- PERISCOPE CAPITAL INC.SC 13G/A, 1 filing Feb 14, 202266
- Magnetar Financial LLCSC 13G/A, 1 filing Jan 7, 202267
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | John KedzierskiChief Executive Officer and President | 47 | $540.0K | $7.5M68 |
| 2025 | Chris KutsorChief Financial Officer | $284.4K | $4.2M68 | |
| 2025 | Robert MarshallChief Revenue Officer | 54 | $338.9K | $3.5M68 |
| 2024 | John KedzierskiChief Executive Officer and President | 47 | $20.8K68 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 13,537,113 | $78.5M | 0.0% | +2,000,590 |
| Vanguard Capital Management LLC | 7,284,475 | $42.2M | 0.0% | +200,840 |
| Stoic Point Capital Management LLC | 6,479,298 | $37.6M | 31.6% | +713,791 |
| Vanguard Portfolio Management LLC | 6,002,387 | $34.8M | 0.0% | +202,126 |
| D. E. Shaw & Co., Inc. | 4,846,031 | $28.1M | 0.0% | +3,157,264 |
| Data Collective IV GP, LLC | 4,590,000 | $26.6M | 33.9% | No change |
| Two Sigma Investments, LP | 4,499,208 | $26.1M | 0.0% | −1,468,013 |
| Emerald Advisers, LLC | 4,227,336 | $24.5M | 0.6% | −105,719 |
| Geode Capital Management, LLC | 4,000,222 | $23.2M | 0.0% | +360,173 |
| State Street Corp | 3,789,950 | $22.0M | 0.0% | +321,144 |
| Needham Investment Management LLC | 3,075,000 | $17.8M | 0.5% | +1,825,000 |
| SCS Capital Management LLC | 2,934,579 | $17.0M | 0.2% | −21,580 |
| Emerald Mutual Fund Advisers Trust | 2,667,589 | $15.5M | 0.5% | No change |
| Morgan Stanley | 1,918,832 | $11.1M | 0.0% | +661,401 |
| Oberweis Asset Management Inc/ | 1,823,949 | $10.6M | 0.2% | +152,000 |
| Goldman Sachs Group Inc | 1,722,971 | $10.0M | 0.0% | +722,542 |
| Algert Global LLC | 1,669,103 | $9.7M | 0.1% | +848,317 |
| Qube Research & Technologies Ltd | 1,634,953 | $9.5M | 0.0% | +470,435 |
| Peregrine Capital Management LLC | 1,529,145 | $8.9M | 0.3% | −77,837 |
| Northern Trust Corp | 1,341,062 | $7.8M | 0.0% | +142,612 |
| Trexquant Investment LP | 1,293,182 | $7.5M | 0.0% | +366,091 |
| Jane Street Group, LLC | 1,255,382 | $7.3M | 0.0% | −324,739 |
| Charles Schwab Investment Management Inc | 1,249,171 | $7.2M | 0.0% | +60,905 |
| Granahan Investment Management, LLC | 1,235,954 | $7.2M | 0.3% | New |
| Citadel Advisors LLC | 1,225,168 | $7.1M | 0.0% | −297,655 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Evolv Technologies Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAREvolv Technologies Holdings, Inc.1
- CIK0001805385
- Employer ID (EIN)84-44738404
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)3577 Computer Peripheral Equipment, NEC1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address500 Totten Pond Road, 4Th Floor, Waltham, MA 024511
- Phone781-374-81001
- Shares outstanding181,126,146 as of Aug 4, 202610
- Public float$999.0M as of Jun 30, 20254
- AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts PCAOB ID 238; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMar 10, 20201
- Filings549 in all: 4 (219), 8-K (72), 425 (39), 3 (37), 144 (31), 10-Q (18), 424B3 (17), SC 13G/A (11)1
All 41 form types
SC 13G (10), CORRESP (7), EFFECT (7), 10-K (6), UPLOAD (6), DEF 14A (5), DEFA14A (5), SC 13D (5), SCHEDULE 13G/A (5), 4/A (4), ARS (4), NT 10-Q (4), POS AM (4), S-1/A (4), SC 13D/A (3), SD (3), 10-Q/A (2), 25-NSE (2), S-1 (2), S-4/A (2), S-8 (2), SCHEDULE 13D/A (2), 10-K/A (1), 424B4 (1), 8-A12B (1), 8-K/A (1), CERT (1), DRS (1), NT 10-K (1), POS EX (1), PRE 14A (1), S-4 (1), SCHEDULE 13D (1)
- Latest filingsAnnual report (10-K) Mar 10, 2026
Quarterly report (10-Q) Aug 11, 2026
Proxy statement (DEF 14A) Apr 30, 2026
Latest 8-K (8-K) Aug 11, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Class A common stock, par value $0.0001 per share | EVLV | Nasdaq |
| Warrants to purchase one share of Class A common stock | EVLVW | Nasdaq |
From the cover page of the 10-K filed Mar 10, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks Evolv Technologies Holdings, Inc. names in Item 1A of its 10-K filed Mar 10, 2026: 44 risks under these headings, as written.4
- Risks Related to Our Restatement and Internal Controls
- Material weaknesses in our internal control over financial reporting, which contributed to the previously disclosed restatement of our prior period financial statements expose us to significant risks and uncertainties.
- Risks Related to Our Business and Operations
- We have a history of losses. We have not been profitable historically and may not achieve or maintain profitability in the future.
- Our operating results may fluctuate for a variety of reasons, including our failure to close large volume opportunity customer sales.
- If we fail to maintain successful relationships with our reseller partners, or if our partners fail to perform, our ability to market, sell and distribute our products will be limited.
- Increases in component costs, long lead times, supply shortages, supply changes, and tariffs could disrupt our supply chain and have an adverse effect on our business, financial condition, and operating results.
- Delays in production, increases in prices charged or the loss of a limited or sole source supplier could have an adverse effect on our business, financial condition and operating results.
- Defects and poor quality which require rework, replacement parts or systems and associated costs of service could have an adverse effect on our business and results of operations.
- We recognize a substantial portion of our revenue ratably over the term of our agreements with customers and, as a result, downturns or upturns in sales may not be immediately reflected in our operating results.
- If we are unable to compete effectively with new entrants and other potential competitors, our sales and profitability could be adversely affected.
- A portion of our revenue is generated by sales to government entities and such sales are subject to a number of challenges and risks.
The other 34 risks
- We could lose customers and revenue if there are changes in the spending policies or budget priorities for government funding of colleges, universities, K-12 schools and other education providers.
- We may acquire or invest in other companies or technologies in the future, which could divert management’s attention, fail to meet our expectations, result in additional dilution to our stockholders, increase expenses, disrupt our operations or otherwise harm our operating results.
- Risks Related to Our Industry and Products
- If our products fail or are perceived to fail to detect threats such as a firearm or other potential weapon or explosive device, or if our products contain undetected errors or defects, this could have an adverse effect on our business and results of operations.
- If our customers are unable to implement our products successfully, or if we fail to effectively assist our customers in installing our products and provide effective ongoing support and training, customer perceptions of our products may be impaired, or our reputation and brand may suffer.
- We face the risk of losing recurring revenue and forecasting certainty if customers choose not to renew their typical four‑year subscriptions or if renewal terms result in lower revenue than expiring agreements, and significant losses if returned systems cannot be profitably redeployed.
- The loss of designation of our Evolv Express system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act could result in adverse reputational and financial consequences.
- The AI-based weapons detection for security screening market is new and evolving and may not grow as expected or may develop more slowly or differently than we expect.
- We use AI and machine learning in our development process and in our AI-based weapon detection products, which could present risks and challenges to our business.
- condition and results of operation. See – “We are subject to government regulation and other legal obligations, particularly related to privacy, data protection, information security, and product marketing and our actual or perceived failure to comply with such obligations could harm our business.”
- Our expansion into international markets exposes us to additional operational, regulatory, and compliance risks that could adversely affect our business.
- Our growth potential outside the U.S. may be limited or vary due to differences in security threats, customer perceptions, regulatory environments, and international market dynamics, as well as our own expansion and investment priorities.
- If we do not successfully anticipate market needs and enhance our existing products or develop new products that meet those needs on a timely basis, we may not be able to compete effectively and our ability to generate revenues will suffer.
- We incorporate technology and components from third parties into our products, and our inability to obtain or maintain rights to the technology could harm our business.
- Our use of “open source” software could subject our proprietary software to certain disclosure obligations, expose us to security risks, and negatively affect our ability to offer our products and subject us to possible litigation.
- Our business depends on the reliability, availability, and performance of our information technology systems, including key internal enterprise software solutions, and any failure or disruption of these systems could materially and adversely affect our business.
- Our products and operations collect and store personal data about individuals, including our customers, their visitors, and our employees, as well as other proprietary business and confidential information, which exposes us to cybersecurity risks that could result in additional costs and liabilities or inhibit sales of our products.
- Risks Related to Our Human Capital
- If we do not effectively expand, train, and retain qualified sales and marketing personnel, we may be unable to acquire new customers or sell additional products to successfully pursue our growth strategy.
- We are dependent on the continued services and performance of our senior management and other key employees, as well as on our ability to successfully hire, train, manage, and retain qualified personnel, especially those in sales and marketing and research and development.
- Risks Related to Our Intellectual Property
- Our intellectual property rights are valuable and any inability to protect our proprietary technology and intellectual property rights could substantially harm our business and operating results.
- Assertions by third parties of infringement or other violations by us of their intellectual property rights, whether or not correct, could result in significant costs and harm to our business and operating results.
- The measures we take to protect our trade secrets may not adequately prevent disclosure of trade secrets and other proprietary information.
- Legal and Regulatory Risks
- We are subject to government regulation and other legal obligations, particularly related to privacy, data protection, information security, and product marketing and our actual or perceived failure to comply with such obligations could harm our business.
- Failure to comply with applicable anti-corruption legislation, export controls, economic sanctions and tax laws could result in fines and criminal penalties and materially and adversely affect our business, financial condition, and results of operations.
- We are subject to government investigations, regulatory enforcement proceedings and litigation relating to our business conduct, marketing practices, financial restatement and investigation, which could result in significant penalties, injunctive relief and harm to our business.
- Risks Related to Our Financial Condition and Liquidity
- There are risks related to our ability to utilize net operating loss carryforwards as well as research and development tax credit carryforwards to offset future taxable income or tax liabilities.
- We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
- Our existing and future debt obligations may adversely affect our financial condition and future financial results.
- Our Senior Secured Credit Facilities contain affirmative and negative covenants, including financial covenants, that may limit our operating flexibility.
- Risks Related to Our Common Stock and Warrants
- The market price of our common stock and warrants has been and may continue to be highly volatile, and you may lose some or all of your investment.
- Certain of our warrants are accounted for as liabilities and the changes in value of such warrants could have a material effect on our financial results.
- Certain of our earn-out shares and contingently issuable founder shares are accounted for as liabilities while the contingently returnable founder shares are accounted for as assets. Changes in the fair value of such shares could have a material effect on our financial results.
- General Risk Factors
- Increasing attention to, and evolving expectations for, sustainability initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business.
- If securities or industry analysts do not publish research or reports about us, or publish negative reports, our stock price and trading volume could decline.
- Our business operations are vulnerable to disruption due to natural or other disasters, including climate-related events, strikes and other events beyond our control.
Legal proceedings
Information pertaining to legal proceedings can be found in Note 19, Commitments and Contingencies, in the notes to the consolidated financial statements in this Form 10-K and is incorporated by reference herein.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARMario Ramos, Chief financial officer
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27SEC EDGARHenrik Kuhl, Board member
- 28SEC EDGARRichard A. Shapiro, Board member
- 29SEC EDGARDavid Mounts Gonzales, Board member
- 30SEC EDGARRajan Naik, Board member
- 31SEC EDGARJohn Kedzierski, Board member
- 32SEC EDGARBilal Zuberi, Board member
- 33SEC EDGARDavid J. Orfao, Board member
- 34SEC EDGARKevin M. Charlton, Board member
- 35SEC EDGARKimberly H. Sheehy, Board member
- 36SEC EDGARMahesh Saptharishi, Board member
- 37SEC EDGARMerline Saintil, Board member
- 38SEC EDGARBrian Mathis, Board member
- 39SEC EDGARCharles Mathew Goldman, Board member
- 40SEC EDGARKathleen M. Harris, Board member
- 41SEC EDGARMarc Saiontz, Board member
- 42SEC EDGARNeil Glat, Board member
- 43SEC EDGARSezaneh Taherian, Board member
- 44SEC EDGARResults of operations
- 45SEC EDGAROther events
- 46SEC EDGARShareholder vote
- 47SEC EDGARFinancial statements and exhibits
- 48SEC EDGARResults of operations
- 49SEC EDGARResults of operations
- 50
- 51SEC EDGARResults of operations
- 52
- 53SEC EDGAREntered a material agreement
- 54SEC EDGARRegulation FD disclosure
- 55SEC EDGARShareholder vote
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68